CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 133 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 3.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $76,000 | +123.5% | 22,680 | +100.0% | 0.01% | 0.0% |
| Q3 2020 | $34,000 | -34.6% | 11,340 | 0.0% | 0.01% | -43.8% |
| Q2 2020 | $52,000 | +18.2% | 11,340 | 0.0% | 0.02% | -5.9% |
| Q1 2020 | $44,000 | +2.3% | 11,340 | 0.0% | 0.02% | +6.2% |
| Q4 2019 | $43,000 | -28.3% | 11,340 | 0.0% | 0.02% | -33.3% |
| Q3 2019 | $60,000 | +17.6% | 11,340 | -14.7% | 0.02% | +14.3% |
| Q2 2019 | $51,000 | -19.0% | 13,300 | +8.1% | 0.02% | -22.2% |
| Q1 2019 | $63,000 | +162.5% | 12,300 | 0.0% | 0.03% | +107.7% |
| Q4 2018 | $24,000 | – | 12,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |